Patient Education
Plain-language education on the science of weight loss, GLP-1 medications, nutrition, and the medical reality behind what works — and what doesn't.
Body shaming has been treated as motivation for decades. The research says it does the opposite. Here's what the science actually shows — and why compassionate, clinical support works.
Semaglutide, tirzepatide, oral GLP-1s, triple agonists — the weight loss medication landscape has evolved rapidly. Here's a clear, current breakdown of where things stand in 2026.
Ultra-processed foods are engineered to override the biological signals that tell you when to stop eating. Understanding the neuroscience explains why GLP-1 therapy works where dieting alone often doesn't.
The 1992 USDA Food Pyramid told America to fear fat and eat 11 servings of grains a day. Here's what went wrong, what the evidence actually shows, and how to eat for real weight loss today.
These four articles are a sample of our comprehensive patient education library — covering GLP-1 medications, nutrition science, lifestyle strategies, and more. Explore the complete library for free, no login required.
These sources address the topics identified below. They provide general education, not individualized medical advice, a clinic endorsement or a prediction of your results. Prescription treatment requires evaluation by a licensed provider; eligibility, medication and dosing depend on individual circumstances.
NIH — National Institute of Diabetes and Digestive and Kidney Diseases
Prescription Medications to Treat Overweight & ObesityWeight-management medication eligibility, appetite, lifestyle support and individualized treatment decisions.
Mayo Clinic
Prescription weight-loss drugsPotential benefits, side effects, eligibility and the role of ongoing professional care.
Cleveland Clinic
GLP-1 AgonistsGLP-1 mechanisms, gastrointestinal effects, risks and when to contact a healthcare provider.
U.S. Food and Drug Administration
FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight LossLack of FDA approval for compounded drugs, dosing errors, quality concerns and limits on compounding.
John P. H. Wilding, Rachel L. Batterham, Salvatore Calanna, et al.; STEP 1 Study Group · New England Journal of Medicine · 2021
Research published in the New England Journal of Medicine reported greater mean weight reduction with semaglutide plus lifestyle intervention than with placebo in the studied population. This was not a study of Sarasota Trim Clinic or compounded medication, and individual results vary.
Ania M. Jastreboff, Louis J. Aronne, Nadia N. Ahmad, et al.; SURMOUNT-1 Investigators · New England Journal of Medicine · 2022
Research published in the New England Journal of Medicine reported weight reduction across the tirzepatide groups during a 72-week trial with lifestyle intervention. Results depended on the trial regimen and population, do not establish compounded-product equivalence, and are not a clinic outcome or a guarantee.
Daisuke Hayashi, Caitlyn Edwards, Jennifer A. Emond, Diane Gilbert-Diamond, Melissa Butt, Andrea Rigby and Travis D. Masterson · Nutrients · 2023
Research published in Nutrients reported a conceptual framework for food-cue reactivity and discussed anecdotal reports of reduced food noise. This narrative review is not proof that a particular treatment will eliminate food-related thoughts.
Priya Sumithran, Luke A. Prendergast, Elizabeth Delbridge, et al. · New England Journal of Medicine · 2011
Research published in the New England Journal of Medicine reported persistent changes in appetite-related hormones and hunger after diet-induced weight loss in the studied group. It does not establish a single cause of weight regain for every person.
Ready to start your weight loss journey?
South Florida Trim Clinic is where the Trim Clinic Network began, and Sarasota Trim Clinic is part of that network. Care is provided by licensed medical providers and is personalized to each patient, with no membership fees ever. Telehealth is offered where legally and clinically appropriate, and any prescription depends on a provider's evaluation and your eligibility.